Recruiting
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC
NCT06439771
- Conditions
- Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China